Antaros Medical is discussing advanced MR and PET imaging techniques in heart failure at the HFpEF Summit

Edvin Johansson (Senior Director MR Imaging at Antaros Medical) will be presenting this week at the 2nd Annual HFpEF & HCM Drug Discovery & Development Summit. This talk will cover how various advanced Magnetic Resonance (MR) and Positron Emission Tomography (PET) imaging techniques can complement established methods to further our understanding of heart failure. Moreover, Edvin will also discuss how imaging provides an opportunity to consider multiple organ effects, which can add value in heart failure drug development. This year’s event takes place from January 24 – 26 in Boston, MA.

Global prevalence of heart failure is rising, and it is now estimated that 1 in 5 have the lifetime risk of developing heart failure. Heart failure, a condition where the muscles of the heart are unable to sufficiently pump blood throughout the body, is thought to have many possible causes, including coronary artery disease, high blood pressure, or previous myocardial infarction (heart attack). Furthermore, it has a very poor prognosis: an estimated 45-60% of patients admitted to hospital with heart failure will die within 5 years. Heart failure is also associated with damage to the liver and kidneys.

Cardiac Magnetic Resonance (CMR) imaging is already an established non-invasive tool for investigating certain aspects of heart structure and function. However, using advanced MR and PET imaging techniques, such as myocardial efficiency or fatty acid utilisation, can complement established methods by providing more in-depth information about treatment effects. Cardiac imaging can also be combined with the imaging of other organs (i.e., liver or kidneys) to investigate treatment effects across multiple organs in heart failure and other diseases where such effects are often linked.

To find out more, join us at the HFpEF Summit on Wednesday 25 January @ 11:40 EST to hear Edvin’s talk “Imaging in heart failure: advancing beyond routine clinical techniques”. You can also read more about our work in cardiovascular disease in our Publications.

Share on Linkedin Share on Twitter